151 related articles for article (PubMed ID: 18373979)
1. An N-ethyl-N-nitrosourea-induced mutation in N-acetyltransferase 1 in mice.
Erickson RP; McQueen CA; Chau B; Gokhale V; Uchiyama M; Toyoda A; Ejima F; Maho N; Sakaki Y; Gondo Y
Biochem Biophys Res Commun; 2008 May; 370(2):285-8. PubMed ID: 18373979
[TBL] [Abstract][Full Text] [Related]
2. Syrian hamster monomorphic N-acetyltransferase (NAT1) alleles: amplification, cloning, sequencing, and expression in E. coli.
Ferguson RJ; Doll MA; Rustan TD; Baumstark BR; Hein DW
Pharmacogenetics; 1994 Apr; 4(2):82-90. PubMed ID: 8081415
[TBL] [Abstract][Full Text] [Related]
3. Identification of amino acids imparting acceptor substrate selectivity to human arylamine acetyltransferases NAT1 and NAT2.
Goodfellow GH; Dupret JM; Grant DM
Biochem J; 2000 May; 348 Pt 1(Pt 1):159-66. PubMed ID: 10794727
[TBL] [Abstract][Full Text] [Related]
4. Arylamine N-acetyltransferase aggregation and constitutive ubiquitylation.
Liu F; Zhang N; Zhou X; Hanna PE; Wagner CR; Koepp DM; Walters KJ
J Mol Biol; 2006 Aug; 361(3):482-92. PubMed ID: 16857211
[TBL] [Abstract][Full Text] [Related]
5. Arylamine N-acetyltransferases. Expression in Escherichia coli, purification, and substrate specificities of recombinant hamster monomorphic and polymorphic isozymes.
Wagner CR; Bergstrom CP; Koning KR; Hanna PE
Drug Metab Dispos; 1996 Feb; 24(2):245-53. PubMed ID: 8742238
[TBL] [Abstract][Full Text] [Related]
6. Generation and functional characterization of arylamine N-acetyltransferase Nat1/Nat2 double-knockout mice.
Sugamori KS; Wong S; Gaedigk A; Yu V; Abramovici H; Rozmahel R; Grant DM
Mol Pharmacol; 2003 Jul; 64(1):170-9. PubMed ID: 12815173
[TBL] [Abstract][Full Text] [Related]
7. Polymorphism p.Val231Ile alters substrate selectivity of drug-metabolizing arylamine N-acetyltransferase 2 (NAT2) isoenzyme of rhesus macaque and human.
Tsirka T; Boukouvala S; Agianian B; Fakis G
Gene; 2014 Feb; 536(1):65-73. PubMed ID: 24333853
[TBL] [Abstract][Full Text] [Related]
8. Effect of arylamine acetyltransferase Nat3 gene knockout on N-acetylation in the mouse.
Sugamori KS; Brenneman D; Wong S; Gaedigk A; Yu V; Abramovici H; Rozmahel R; Grant DM
Drug Metab Dispos; 2007 Jul; 35(7):1064-70. PubMed ID: 17403913
[TBL] [Abstract][Full Text] [Related]
9. Developmental expression of N-acetyltransferases in C57BI/6 mice.
Mitchell MK; Futscher BW; McQueen CA
Drug Metab Dispos; 1999 Feb; 27(2):261-4. PubMed ID: 9929513
[TBL] [Abstract][Full Text] [Related]
10. Efficient gene-driven germ-line point mutagenesis of C57BL/6J mice.
Michaud EJ; Culiat CT; Klebig ML; Barker PE; Cain KT; Carpenter DJ; Easter LL; Foster CM; Gardner AW; Guo ZY; Houser KJ; Hughes LA; Kerley MK; Liu Z; Olszewski RE; Pinn I; Shaw GD; Shinpock SG; Wymore AM; Rinchik EM; Johnson DK
BMC Genomics; 2005 Nov; 6():164. PubMed ID: 16300676
[TBL] [Abstract][Full Text] [Related]
11. Differences between murine arylamine N-acetyltransferase type 1 and human arylamine N-acetyltransferase type 2 defined by substrate specificity and inhibitor binding.
Laurieri N; Kawamura A; Westwood IM; Varney A; Morris E; Russell AJ; Stanley LA; Sim E
BMC Pharmacol Toxicol; 2014 Nov; 15():68. PubMed ID: 25432241
[TBL] [Abstract][Full Text] [Related]
12. NMR-based model reveals the structural determinants of mammalian arylamine N-acetyltransferase substrate specificity.
Zhang N; Liu L; Liu F; Wagner CR; Hanna PE; Walters KJ
J Mol Biol; 2006 Oct; 363(1):188-200. PubMed ID: 16959263
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic characterization of a new Grin1 mutant mouse generated by ENU mutagenesis.
Furuse T; Wada Y; Hattori K; Yamada I; Kushida T; Shibukawa Y; Masuya H; Kaneda H; Miura I; Seno N; Kanda T; Hirose R; Toki S; Nakanishi K; Kobayashi K; Sezutsu H; Gondo Y; Noda T; Yuasa S; Wakana S
Eur J Neurosci; 2010 Apr; 31(7):1281-91. PubMed ID: 20345915
[TBL] [Abstract][Full Text] [Related]
14. Substrate selectivity of mouse N-acetyltransferases 1, 2, and 3 expressed in COS-1 cells.
Estrada-Rodgers L; Levy GN; Weber WW
Drug Metab Dispos; 1998 May; 26(5):502-5. PubMed ID: 9571233
[TBL] [Abstract][Full Text] [Related]
15. Only low levels of exogenous N-acetyltransferase can be achieved in transgenic mice.
Cao W; Chau B; Hunter R; Strnatka D; McQueen CA; Erickson RP
Pharmacogenomics J; 2005; 5(4):255-61. PubMed ID: 16041393
[TBL] [Abstract][Full Text] [Related]
16. Molecular genetic basis of rapid and slow acetylation in mice.
Martell KJ; Vatsis KP; Weber WW
Mol Pharmacol; 1991 Aug; 40(2):218-27. PubMed ID: 1875909
[TBL] [Abstract][Full Text] [Related]
17. Human acetyl CoA:arylamine N-acetyltransferase variants generated by random mutagenesis.
Summerscales JE; Josephy PD
Mol Pharmacol; 2004 Jan; 65(1):220-6. PubMed ID: 14722254
[TBL] [Abstract][Full Text] [Related]
18. Confirmation of the role of N-acetyltransferase 2 in teratogen-induced cleft palate using transgenics and knockouts.
Erickson RP; Cao W; Acuña DK; Strnatka DW; Hunter RJ; Chau BT; Wakefield LV; Sim E; McQueen CA
Mol Reprod Dev; 2008 Jun; 75(6):1071-6. PubMed ID: 18161794
[TBL] [Abstract][Full Text] [Related]
19. Large-scale N-ethyl-N-nitrosourea mutagenesis of mice--from phenotypes to genes.
Rathkolb B; Fuchs E; Kolb HJ; Renner-Müller I; Krebs O; Balling R; Hrabé de Angelis M; Wolf E
Exp Physiol; 2000 Nov; 85(6):635-44. PubMed ID: 11187959
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel point mutation of mouse proto-oncogene c-kit through N-ethyl-N-nitrosourea mutagenesis.
Ruan HB; Zhang N; Gao X
Genetics; 2005 Feb; 169(2):819-31. PubMed ID: 15731517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
